Trials / Completed
CompletedNCT00311441
Study of the Safety, Tolerability and Immune Response of TBE Vaccines Administered to Healthy Children
A Phase IV, Randomized, Controlled, Single-Blind, Multi-Center Study in Children to Evaluate the Safety, Tolerability and Immunogenicity of Two TBE Vaccines Administered According to Two Different Schedules.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 300 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 1 Year – 10 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, immunogenicity and tolerability of TBE vaccines administered to children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Tick-Borne Encephalitis vaccine |
Timeline
- Start date
- 2005-03-01
- First posted
- 2006-04-06
- Last updated
- 2008-03-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00311441. Inclusion in this directory is not an endorsement.